Trial · NCT03679247
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
NCT03679247, Not applicable, Completed, Brigham and Women's Hospital; results first posted 2024-11-26
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease. Trials, record NCT03679247. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03679247
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
- NCT number
- NCT03679247
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,026 participants, actual
- Lead sponsor
- Brigham and Women's Hospital
- Conditions
- Chronic Kidney Diseases, Hypertension
- Interventions
- Intervention, Control
- First posted
- 2018-09-20
- Last updated
- 2024-11-26
- Results first posted
- 2024-11-26
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days | 180 days | Difference in SBP from baseline to 180 days |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days | 180 days | mmHg | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days | Intervention | 14.6 | 95% Confidence Interval 13.1 to 16.0 | mmHg | |
| Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days | Control | 11.7 | 95% Confidence Interval 10.2 to 13.1 | mmHg |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intervention | 1,029 | 87 |
| Overall Study | STARTED | Control | 997 | 87 |
| Overall Study | COMPLETED | Intervention | 1,029 | 87 |
| Overall Study | COMPLETED | Control | 997 | 87 |
| Overall Study | NOT COMPLETED | Intervention | 0 | 0 |
| Overall Study | NOT COMPLETED | Control | 0 | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intervention | 15 | 1,029 |
| Total, all-cause mortality | Control | 19 | 997 |
| Total, other adverse events | Intervention | 0 | 1,029 |
| Total, other adverse events | Control | 0 | 997 |
| Total, serious adverse events | Intervention | 0 | 1,029 |
| Total, serious adverse events | Control | 0 | 997 |
Source ClinicalTrials.gov
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01DK116898 | Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial | SAMAL, LIPIKA; BLECKER, SAUL B.; FELDSTEIN, DAVID ALAN | BRIGHAM AND WOMEN'S HOSPITAL | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2018 to 2025 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention vs Control: deaths from any cause | Trial comparisons |
| Intervention vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03679247
GET https://conductscience.org/api/trials/v1/NCT03679247/registered